...
首页> 外文期刊>Medicine. >Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988–2011)
【24h】

Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988–2011)

机译:年轻人和老年人对结直肠癌的临床病理特征和生存结果:SEER 9注册数据(1988-2011年)的基于人群的队列研究

获取原文

摘要

The incidence of colorectal cancer (CRC) in young adults is rising. We aimed to analyze the clinicopathological characteristics and survival outcomes of young versus elderly CRC patients. All patients diagnosed with CRC in the Surveillance, Epidemiology, and End Results program data (1988–2011) from the United States were evaluated. They were divided into 3 groups by age at diagnosis: group 1 (20–40 years old), group 2 (41–50 years old), and group 3 (>50 years old). The clinicopathological characteristics and CRC-specific survival (CRC-SS) were evaluated and compared among the 3 groups. A total of 279,623 CRC patients were included: 6700 (2.4%) in group 1, 19,385 (6.9%) in group 2, and 253,538 (90.7%) in group 3. Young CRC patients had more tumors located in rectum, fewer cases with multiple tumors, later stage, more mucinous carcinoma and signet ring-cell carcinoma, more poor differentiated tumors, and more lymph nodes (no. ≥12) examined. The 5-year CRC-SS rates of patients in groups 1, 2, and 3 were 65.1%, 67.1%, and 62.8%, respectively (group 1 vs group 2, P = 0.001; group 1 vs group 3, P 50 years old) age was an independent predictor of poor prognosis (hazard ratio, 1.545; 95% confidence interval, 1.456–1.639; P < 0.001). Young CRC patients had later stage presentation and more aggressive pathological features, but better survival. CRC patients aged 41 to 50 years had best CRC-SS in contrast to patients in another 2 age groups.
机译:年轻人大肠癌的发病率正在上升。我们旨在分析年轻与老年CRC患者的临床病理特征和生存结果。评估了来自美国的监测,流行病学和最终结果计划数据(1988-2011年)中诊断为CRC的所有患者。根据诊断时的年龄分为三组:第一组(20-40岁),第二组(41-50岁)和第三组(> 50岁)。评估并比较3组的临床病理特征和CRC特异性生存率(CRC-SS)。总共包括279,623名CRC患者:第1组为6700(2.4%),第2组为19,385(6.9%),第3组为253,538(90.7%)。多发性肿瘤,晚期,粘液性癌和印戒性环状细胞癌较多,分化较差的肿瘤和淋巴结较多(≥12)。第1、2和3组患者的5年CRC-SS发生率分别为65.1%,67.1%和62.8%(第1组与第2组,P = 0.001;第1组与第3组,P 50岁)年龄是不良预后的独立预测因子(危险比1.545; 95%置信区间1.456-1.639; P <0.001)。年轻的CRC患者表现较晚,表现出更具侵略性的病理特征,但存活率更高。与其他2个年龄组的患者相比,年龄在41至50岁的CRC患者的CRC-SS最好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号